enkephalinamide-met, ala(2)- and Alloxan Diabetes

enkephalinamide-met, ala(2)- has been researched along with Alloxan Diabetes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Severson, K; Tackett, RL	1

Other Studies

1 other study(ies) available for enkephalinamide-met, ala(2)- and Alloxan Diabetes

Article	Year
Enhanced hemodynamic response to [D-ALA2,D-MET5]-methionine enkephalin (DAME) in streptozotocin-induced diabetic rats is reversed by insulin replacement. Life sciences, 1998, Volume: 62, Issue:24 Topics: Animals; Blood Flow Velocity; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Enkephalin, Methionine; Ganglionic Blockers; Hexamethonium; Hindlimb; Insulin; Male; Naloxone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Vascular Resistance	1998

Article

Year

Enhanced hemodynamic response to [D-ALA2,D-MET5]-methionine enkephalin (DAME) in streptozotocin-induced diabetic rats is reversed by insulin replacement.

Life sciences, 1998, Volume: 62, Issue:24

Topics: Animals; Blood Flow Velocity; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Enkephalin, Methionine; Ganglionic Blockers; Hexamethonium; Hindlimb; Insulin; Male; Naloxone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Vascular Resistance

1998